Armata Pharmaceuticals (ARMP) Current Leases (2019 - 2026)

Armata Pharmaceuticals (ARMP) has 8 years of Current Leases data on file, last reported at $4.6 million in Q1 2026.

• For the quarter ending Q1 2026, Current Leases rose 3.01% year-over-year to $4.6 million; the trailing twelve-month figure through Mar 2026 stood at $4.6 million (up 3.01% YoY), and the FY2025 full-year result was $4.6 million, up 3.0% from the prior year.
• Current Leases grew to $4.6 million in Q1 2026, from $4.6 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $17.0 million in Q4 2022 to a low of $1.5 million in Q1 2022.
• A 5-year average of $7.0 million and a median of $4.6 million in 2026 frame the typical range for Current Leases.
• Across the five-year window, Current Leases jumped 1027.3% in 2022 and plunged 62.85% in 2024, its largest moves.
• Tracing ARMP's Current Leases over 5 years: stood at $17.0 million in 2022, then sank by 44.27% to $9.5 million in 2023, then slumped by 53.26% to $4.4 million in 2024, then gained by 3.0% to $4.6 million in 2025, then climbed by 0.64% to $4.6 million in 2026.
• Business Quant data shows ARMP's Current Leases at $4.6 million in Q1 2026, $4.6 million in Q4 2025, and $4.5 million in Q3 2025.